Amiloxate
![]() | |
Names | |
---|---|
Preferred IUPAC name
3-Methylbutyl (2E)-3-(4-methoxyphenyl)prop-2-enoate | |
Other names
Isopentyl 4-methoxycinnamate; Isoamyl p-methoxycinnamate
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.068.798 ![]() |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C15H20O3 | |
Molar mass | 248.322 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Amiloxate is a sunscreening agent. It is approved for use in the European Union and is undergoing regulatory evaluation in the United States.[1][2]
See also[]
References[]
- ^ Brian Palmer (23 April 2014). "Burned by Bureaucracy: Why is the FDA stalling on newer and better sunscreens?". Slate.com.
- ^ Britt Erickson (May 12, 2014). "Sunscreen Delays". Chemical & Engineering News. 92 (19): 27. doi:10.1021/cen-09219-govpol2.
Categories:
- Sunscreening agents
- Cinnamate esters
- Ethers
- Ester stubs